Estrogen and progesterone receptor status determined by the ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: Prognostic significance

Journal of Surgical Oncology

Volumn 61, Issue 3, 1996, Pages 177-184

  Layfield, Lester J ^a   Saria, Elizabeth A ^b   Conlon, Debbi H ^a   Kerns, Billie Jo M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BD Technologies   (United States)

Author keywords

Automated immunohistochemistry; ER; Image cytometry; PgR

Indexed keywords

CHARCOAL; DEXTRAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AUTOMATION; BREAST CARCINOMA; CANCER SURVIVAL; COMPUTER ANALYSIS; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

AGED; AUTOMATION; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CHARCOAL; COLORING AGENTS; DEXTRANS; FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE;

EID: 0029869018     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199603)61:3<177::AID-JSO3>3.0.CO;2-8     Document Type: Article

References (47)

1. Russo J, Frederick J, Ownby HE, et al.: Predictors of recurrence and survival of patients with breast cancer. Am J Clin Pathol 88:123-131, 1987.
2. Stenkvist B, Bengtsson E, Eriksson O, et al.: Histopathological systems of breast cancer classifications. Reproducibility and clinical significance. J Clin Pathol 36:392-398, 1983.
3. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed 15 years. Br J Cancer 11:359-377, 1957.
4. Schiodt T: "Breast Carcinomas - A Histologic and Prognostic Study of 650 Follow-up Cases." Copenhagen: Munksgaard, 1966.
5. Bianchi S, Paglierani M, Zampi G, et al.: Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients. Cancer 72:120-125, 1993.
6. Bouzuber N, Walker KJ, Griffiths K, et al.: Ki-67 immunostaining in primary breast cancer. Pathological and clinical associations. Br J Cancer 59:943-947, 1989.
7. Tubiana M, Pejovic MH, Koscielay S, et al.: Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int J Cancer 44:17-22, 1989.
8. Elias JM: Immunohistochemical and biochemical measurement of sex steroid receptors. In Elias JM (ed): "Immunohistopathology: A Practical Approach to Diagnosis." Chicago: ASCP Press, 1990, p 348-403.
9. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46:2884-2888, 1980.
10. Wittliff JL: Steroid-hormone receptors in breast cancer. Cancer 53:630-643, 1984.
11. Allred DC: Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer. Am J Clin Pathol 99:1-3, 1993.
12. Osborne CK: Receptors. In Harris JR, Hellman S, Henderson IC, Kinne DW (eds): "Breast Diseases." Philadelphia: JB Lippincott, 1991, p 301-325.
13. Clark GM, McGuire WL: Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 15(2 suppl 1):20-25, 1988.
14. Andersen J, Poulsen HS: Immunohistochemical estrogen receptor determination in paraffin-embedded tissue: Prediction of response to hormonal treatment in advanced breast cancer. Cancer 64:1901-1908, 1989.
15. Baddoura F, Cohen C, Unger E, et al.: Image analysis for quantitation of estrogen receptor in formalin-fixed paraffin embedded sections of breast carcinoma Mod Pathol 4:91-95, 1991.
16. Esteban J, Battifora H, Warsi Z, et al.: Quantification of estrogen receptors on paraffin-embedded tumors by image analysis. Mod Pathol 4:53-57, 1991.
17. Cheng L, Binder SW, Fu YS, Lewin KJ: Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors. Lab Invest 58:346-353, 1988.
18. Hanna W, Mobbs BG: Comparative evaluation of ER-ICA and enzyme immunoassay for the quantilation of estrogen receptors in breast cancer. Am J Clin Pathol 91:182-186, 1989.
19. Helin HJ, Helle MJ, Kallioniemi OP, Isola JJ: Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma: Correlation with histopathology and DNA flow cytometry. Cancer 63:1761-1767, 1989.
20. Masood S, Lu L, Rodenroth N: Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors. Mod Pathol 3:724-728, 1990.
21. Masood S, Dee S, Goldstein JD: Immunohistochemical analysis of progesterone receptors in breast cancer. Am J Clin Pathol 96:59-63, 1991.
22. Pertschak LP, Kim DS, Nayer K, et al.: Immunohistochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic and biochemical correlations and relationship to endocrine response and survival. Cancer 66:1663-1670, 1990.
23. Pertschak LP, Eisenberg KB, Carter AC, Feldman JG: Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response. Cancer 55:1513-1518, 1985.
24. Seymour L, Meyer K, Esser J, et al.: Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods. Am J Clin Pathol 94(suppl 1):S35-S40, 1990.
25. Shintaka IP, Said JW: Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction. Am J Clin Pathol 87:161-167, 1987.
26. Soomro S, Shousha S: Demonstration of progesterone receptors in paraffin wax sections of breast carcinoma. J Clin Pathol 43:671-674, 1990.
27. Tesch M, Shawwa A, Henderson R: Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer. Am J Clin Pathol 99:8-12, 1993.
28. Shimada A, Kimura S, Abe K: Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody. Comparison with that in frozen sections. Proc Natl Acad Sci USA 82:4803-4807, 1985.
29. McCarty KS, Miller LS, Cox EB: Estrogen receptor analysis. Correlation of biochemical and immunohistochemical methods using monoclonal anti-receptor antibodies. Arch Pathol Lab Med 109:716-721, 1985.
30. Charpin C, Martin PM, DeVictor B, et al.: Multiparameteric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas. Analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextrancoated charcoal assay and morphologic data. Cancer Res 48:1578-1586, 1988.
31. Kinsel LB, Szabo E, Greene GL, et al.: Immunocytochemical analysis of estrogen receptors as a predictor prognosis in breast cancer patients. Comparison with quantitative biochemical methods. Cancer Res 49:1052-1056, 1989.
32. Reiner A, Neumeister B, Spona J, et al.: Immunocytochemical localization of estrogen and progesterone receptors and prognosis in human primary breast cancer. Cancer Res 50:7057-7061, 1990.
33. Battifora H: Immunohistochemistry of hormone receptors in routinely processed tissues. The new gold standard. Appl Immunohistochem 2:143-145, 1994.
34. Lundy J, Lozowski M, Sadri D, Mishriki Y: The use of fine-needle aspirates of breast cancers to evaluate hormone receptor status. Arch Surg 125:174-176, 1990.
35. Esteban JM, Kandalaft PL, Mehta P, et al.: Improvement of the quantitation of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis. Am J Clin Pathol 99:32-38, 1993.
36. ™ quantitation of immunocytochemical staining in breast carcinoma samples. Anal Quant Cytol Histol 14:35-40, 1992.
37. Coombes RC, Berger U, McClelland RA, et al.: Prediction of endocrine response in breast cancer by immunocytochemical detection of estrogen receptors in fine-needle aspirates. Lancet (8561):701-703, 1987.
38. Beahrs OH, Henson DE, Hutter RVP, Myers MH (eds): "Manual for Staging of Cancer." 3rd Ed. Philadelphia: JB Lippincott, 1988, p 145-150.
39. Spiessl B, Hermanek P, Scheibe O, Wagner G (eds): "TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors." 3rd Ed. New York: Springer-Verlag, 1989, p 173-183.
40. Bacus S, Flowers JL, Press MF, et al.: The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 90:230-239, 1988.
41. Bacus JW, Grace LJ: Optical microscope system for standardized cell measurements and analysis. Appl Optics 26:3280-3293, 1987.
42. De Cresce R: The CAS 100: A computerized microscope image analysis system. Lab Med 17:163-165, 1986.
43. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
44. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966.
45. Koziol JA, Reid N: On multiple comparisons among k samples subject to unequal patterns of censorship. Commun Statist-Theor Methods A6:1149-1164, 1977.
46. Tarone RE: Tests for trend in life table analysis. Biometrika 62:679-682, 1975.
47. Mauri FA, Veronese S, Frigo B, et al.: ER105 and H222 (ER-ICA) antibodies to human estrogen receptor protein in breast carcinomas: Results of a multicenter comparative study. Appl Immunohistochem 2:157-163, 1994.